Assessment of the long-term safety and efficacy of erenumab during open-label treatment of subjects with chronic migraine

Authors
Category Primary study
ConferenceHeadache
Year 2018
This article has no abstract
Epistemonikos ID: 7d95b921cd966bbb2660e9cf57560b55331da478
First added on: Apr 29, 2026